Oriental Rise Updates on Nasdaq Delisting Decision
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 24 2026
0mins
Oriental Rise provided an update regarding the decision of the Nasdaq Hearings Panel to delist the company's ordinary shares from the Nasdaq Capital Market. On June 22, the company received a written decision from the Panel denying the company's request for continued listing and providing that trading in the company's ordinary shares would be suspended at the open of trading on June 24. Prior to the Panel's decision, the company's 1-for-4 reverse stock split became effective at the open of trading on June 22. On that day, the company's ordinary shares opened at $2.04 per share and closed at $2.42 per share, above Nasdaq's $1.00 requirement. On June 23, the company's counsel received an email from Nasdaq stating that the Panel was reviewing the company's request for reconsideration, that the company would be notified within 15 calendar days, and that the Panel had chosen to stay the suspension while considering the request. On June 24, Nasdaq advised the company's counsel that its prior email had inadvertently omitted the word "not" and should instead have stated that the Panel, in fact, had chosen not to stay the suspension. Accordingly, trading in the company's ordinary shares on Nasdaq was suspended, while the Panel continued to consider the company's request for reconsideration, which is ongoing. The company will continue to pursue its request for reconsideration. If the Panel does not reconsider its decision, the company currently intends to request that the Nasdaq Listing and Hearing Review Council review the Panel's decision. Unless and until the Panel reverses or modifies its decision, or the company is successful in a subsequent appeal, the company expects that its ordinary shares will be quoted in the over-the-counter market under the company's OTC trading symbol, ORISF.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ORIS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ORIS
About ORIS
Oriental Rise Holdings Ltd is an investment holding company primarily engaged in planting, cultivating, processing, and selling primarily-processed tea. The Company mainly operates its business through two segments. The Primarily-processed Teas segment is engaged in the production and sales of primarily-processed white tea and primarily-processed black tea that have been roughly processed by major steps including picking, wilting, drying, and grading. The Refined Teas segment is engaged in the production and sales of refined tea that undertook further processing steps including sifting, removal of branches and stalks, compressing, drying, and packaging. The Company mainly conducts its business in the domestic market.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Oriental Rise Holdings Faces Nasdaq Delisting
- Delisting Decision: Oriental Rise Holdings received a written decision from the Nasdaq Hearings Panel on June 22, 2026, denying its request for continued listing, resulting in the suspension of trading for its ordinary shares on June 24, 2026, which negatively impacts shareholder confidence.
- Reverse Stock Split Impact: Prior to the delisting decision, the company executed a 1-for-4 reverse stock split on June 22, 2026, with post-split trading prices rising from $2.04 to $2.42, which, while above Nasdaq's $1.00 minimum requirement, did not prevent the delisting.
- Emergency Request: The company submitted an emergency request on the evening of June 22 for a stay of the suspension and reconsideration of the delisting decision; however, despite Nasdaq's indication on June 23 that it was reviewing the request, the final decision did not change, highlighting the compliance pressures faced by the company.
- Future Outlook: The company intends to appeal to the Nasdaq Listing and Hearing Review Council if the Panel does not reconsider its decision, and while uncertainties remain, it will continue to strive to maintain compliance and its market position.
See More
Small Caps Surge on Partnerships and Policy Initiatives
- Catheter Precision Partnership: Catheter Precision's Flyte unit partnered with GSE Worldwide to launch Cirrus Vision Jet services aimed at enhancing travel experiences for professional athletes, resulting in a nearly 61% surge in stock price during after-hours trading.
- Quantum Technology Policy: President Trump signed two executive orders to accelerate U.S. quantum technology development, leading to a more than 12% increase in Infleqtion's stock, which expressed support for these initiatives to bolster U.S. leadership in emerging tech.
- Oriental Rise Reverse Split: Oriental Rise Holdings executed a 1-for-4 reverse stock split, causing its stock price to rise 22% in after-hours trading as investors interpreted the reduced share count and increased price as a tightening of trading liquidity.
- Market Sentiment Shift: All three companies experienced strong investor interest in after-hours trading, with retail sentiment for Catheter Precision and Oriental Rise Holdings shifting from 'bullish' to 'extremely bullish', indicating positive market expectations for small-cap stocks.
See More
Oriental Rise Holdings Faces Delisting Risk from Nasdaq
- Delisting Decision: Oriental Rise Holdings received a delisting determination from Nasdaq on April 15, 2026, due to its shares failing to maintain the minimum $1.00 bid price requirement, indicating severe challenges in market performance.
- Compliance Period Limitation: The company is ineligible for the standard 180-day compliance grace period because it executed a 1-for-20 reverse stock split on December 30, 2025, reflecting Nasdaq's stringent regulatory policies on companies that have recently undergone capital restructuring.
- Appeal Opportunity: Oriental Rise has until April 22, 2026, to request a hearing to stay the suspension; if no appeal is filed, trading will be suspended at the market open on April 24, 2026, highlighting the urgency and uncertainty facing the company.
- Future Plans: While the company intends to request a hearing and explore further options to remain listed, a positive outcome is not guaranteed, indicating significant challenges in maintaining its listing status.
See More
Oriental Rise Holdings Faces Nasdaq Delisting
- Delisting Notice: Oriental Rise Holdings received a delisting notice from Nasdaq on April 15, 2026, due to its ordinary shares closing below $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2), which negatively impacts the company's financing capabilities and market perception.
- Reverse Split Impact: The 1-for-20 reverse stock split executed on December 30, 2025, disqualified the company from the 180-day compliance period, exacerbating delisting risks and potentially diminishing investor confidence and stock performance.
- Hearing Request: The company intends to request a hearing before the Nasdaq Hearings Panel by April 22, 2026, which, if granted, will temporarily stay the suspension of trading, demonstrating the company's commitment to compliance and proactive response strategy.
- Compliance Plan Evaluation: The company is currently evaluating options to regain compliance with Nasdaq's listing requirements, and while there is no assurance that the Hearings Panel will approve its request for continued listing, this effort reflects the company's focus on future growth and accountability to investors.
See More
Oriental Rise Holdings Faces Nasdaq Delisting
- Delisting Notice: Oriental Rise Holdings received a delisting notice from Nasdaq on April 15, 2026, due to its ordinary shares closing below $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2), which could severely impact the company's financing capabilities and market reputation.
- Reverse Split Impact: The 1-for-20 reverse stock split executed on December 30, 2025, disqualified the company from a 180-day compliance period, exacerbating delisting risks and potentially leading to decreased investor confidence and stock price performance.
- Hearing Request: The company intends to request a hearing before the Nasdaq Hearings Panel by April 22, 2026, which, if granted, will temporarily stay the suspension of trading; however, the uncertainty of obtaining continued listing approval increases operational risks for the company.
- Compliance Plan Evaluation: Oriental Rise Holdings is currently evaluating options to regain compliance with Nasdaq's continued listing requirements, and while the company expresses intent to meet these standards, the lack of assurance raises concerns about future financial stability.
See More
Oriental Rise Partners with Zhongji New Energy for Solar Integration
- Strategic Cooperation Agreement: Oriental Rise Holdings Limited's subsidiary has signed a strategic cooperation agreement with Zhongji New Energy to deploy solar photovoltaic systems in tea plantations, with a planned capacity of approximately 50 MW and an estimated investment of RMB 165 million, aiming to enhance economic value and promote environmental sustainability through the integration of agriculture and renewable energy infrastructure.
- Project Implementation Details: Under the cooperation framework, Zhongji New Energy will be responsible for project investment, construction, and operation, while Oriental Rise will provide coordination support to ensure smooth project implementation, with a lease term of 20 years and a potential automatic five-year extension upon expiration, subject to industry practices and project conditions.
- Agricultural and Energy Integration: The project will utilize underutilized areas within the tea plantations for photovoltaic power generation, maintaining tea cultivation activities while creating additional economic benefits for the company, aligning with China's promotion of renewable energy development in agricultural environments.
- Sustainability Strategy: The CEO of Oriental Rise stated that this collaboration represents a proactive exploration of sustainable utilization of agricultural infrastructure, enhancing operational efficiency while driving long-term development in tea production and product innovation.
See More
Oriental Rise Holdings Faces Nasdaq Delisting
- Delisting Decision: Oriental Rise Holdings received a written decision from the Nasdaq Hearings Panel on June 22, 2026, denying its request for continued listing, resulting in the suspension of trading for its ordinary shares on June 24, 2026, which negatively impacts shareholder confidence.
- Reverse Stock Split Impact: Prior to the delisting decision, the company executed a 1-for-4 reverse stock split on June 22, 2026, with post-split trading prices rising from $2.04 to $2.42, which, while above Nasdaq's $1.00 minimum requirement, did not prevent the delisting.
- Emergency Request: The company submitted an emergency request on the evening of June 22 for a stay of the suspension and reconsideration of the delisting decision; however, despite Nasdaq's indication on June 23 that it was reviewing the request, the final decision did not change, highlighting the compliance pressures faced by the company.
- Future Outlook: The company intends to appeal to the Nasdaq Listing and Hearing Review Council if the Panel does not reconsider its decision, and while uncertainties remain, it will continue to strive to maintain compliance and its market position.
See More
Small Caps Surge on Partnerships and Policy Initiatives
- Catheter Precision Partnership: Catheter Precision's Flyte unit partnered with GSE Worldwide to launch Cirrus Vision Jet services aimed at enhancing travel experiences for professional athletes, resulting in a nearly 61% surge in stock price during after-hours trading.
- Quantum Technology Policy: President Trump signed two executive orders to accelerate U.S. quantum technology development, leading to a more than 12% increase in Infleqtion's stock, which expressed support for these initiatives to bolster U.S. leadership in emerging tech.
- Oriental Rise Reverse Split: Oriental Rise Holdings executed a 1-for-4 reverse stock split, causing its stock price to rise 22% in after-hours trading as investors interpreted the reduced share count and increased price as a tightening of trading liquidity.
- Market Sentiment Shift: All three companies experienced strong investor interest in after-hours trading, with retail sentiment for Catheter Precision and Oriental Rise Holdings shifting from 'bullish' to 'extremely bullish', indicating positive market expectations for small-cap stocks.
See More
Oriental Rise Holdings Faces Delisting Risk from Nasdaq
- Delisting Decision: Oriental Rise Holdings received a delisting determination from Nasdaq on April 15, 2026, due to its shares failing to maintain the minimum $1.00 bid price requirement, indicating severe challenges in market performance.
- Compliance Period Limitation: The company is ineligible for the standard 180-day compliance grace period because it executed a 1-for-20 reverse stock split on December 30, 2025, reflecting Nasdaq's stringent regulatory policies on companies that have recently undergone capital restructuring.
- Appeal Opportunity: Oriental Rise has until April 22, 2026, to request a hearing to stay the suspension; if no appeal is filed, trading will be suspended at the market open on April 24, 2026, highlighting the urgency and uncertainty facing the company.
- Future Plans: While the company intends to request a hearing and explore further options to remain listed, a positive outcome is not guaranteed, indicating significant challenges in maintaining its listing status.
See More
Oriental Rise Holdings Faces Nasdaq Delisting
- Delisting Notice: Oriental Rise Holdings received a delisting notice from Nasdaq on April 15, 2026, due to its ordinary shares closing below $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2), which negatively impacts the company's financing capabilities and market perception.
- Reverse Split Impact: The 1-for-20 reverse stock split executed on December 30, 2025, disqualified the company from the 180-day compliance period, exacerbating delisting risks and potentially diminishing investor confidence and stock performance.
- Hearing Request: The company intends to request a hearing before the Nasdaq Hearings Panel by April 22, 2026, which, if granted, will temporarily stay the suspension of trading, demonstrating the company's commitment to compliance and proactive response strategy.
- Compliance Plan Evaluation: The company is currently evaluating options to regain compliance with Nasdaq's listing requirements, and while there is no assurance that the Hearings Panel will approve its request for continued listing, this effort reflects the company's focus on future growth and accountability to investors.
See More
Oriental Rise Holdings Faces Nasdaq Delisting
- Delisting Notice: Oriental Rise Holdings received a delisting notice from Nasdaq on April 15, 2026, due to its ordinary shares closing below $1.00 for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2), which could severely impact the company's financing capabilities and market reputation.
- Reverse Split Impact: The 1-for-20 reverse stock split executed on December 30, 2025, disqualified the company from a 180-day compliance period, exacerbating delisting risks and potentially leading to decreased investor confidence and stock price performance.
- Hearing Request: The company intends to request a hearing before the Nasdaq Hearings Panel by April 22, 2026, which, if granted, will temporarily stay the suspension of trading; however, the uncertainty of obtaining continued listing approval increases operational risks for the company.
- Compliance Plan Evaluation: Oriental Rise Holdings is currently evaluating options to regain compliance with Nasdaq's continued listing requirements, and while the company expresses intent to meet these standards, the lack of assurance raises concerns about future financial stability.
See More
Oriental Rise Partners with Zhongji New Energy for Solar Integration
- Strategic Cooperation Agreement: Oriental Rise Holdings Limited's subsidiary has signed a strategic cooperation agreement with Zhongji New Energy to deploy solar photovoltaic systems in tea plantations, with a planned capacity of approximately 50 MW and an estimated investment of RMB 165 million, aiming to enhance economic value and promote environmental sustainability through the integration of agriculture and renewable energy infrastructure.
- Project Implementation Details: Under the cooperation framework, Zhongji New Energy will be responsible for project investment, construction, and operation, while Oriental Rise will provide coordination support to ensure smooth project implementation, with a lease term of 20 years and a potential automatic five-year extension upon expiration, subject to industry practices and project conditions.
- Agricultural and Energy Integration: The project will utilize underutilized areas within the tea plantations for photovoltaic power generation, maintaining tea cultivation activities while creating additional economic benefits for the company, aligning with China's promotion of renewable energy development in agricultural environments.
- Sustainability Strategy: The CEO of Oriental Rise stated that this collaboration represents a proactive exploration of sustainable utilization of agricultural infrastructure, enhancing operational efficiency while driving long-term development in tea production and product innovation.
See More
